The differential expression of ErbB family receptor tyrosine kinases, with ERBB2 significantly upregulated in T1/FTC and ERBB4 and EGFR in T2/MTC, further emphasizes the distinct signaling landscapes of these subtypes. The gene discussed is NTRK1; the disease is medullary thyroid gland carcinoma.